Ameritas Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-29,143
Closed -$5.85M 2017
2026
Q1
$5.85M Sell
29,143
-758
-3% -$157K 0.23% 104
2025
Q4
$6.18M Buy
29,901
+29,662
+12,411% +$5.93M 0.23% 101
2025
Q3
$42.8K Sell
239
-36,224
-99% -$6.17M ﹤0.01% 1145
2025
Q2
$5.88M Sell
36,463
-1,963
-5% -$313K 0.31% 60
2025
Q1
$6.54M Sell
38,426
-983
-2% -$171K 0.26% 75
2024
Q4
$6.55M Sell
39,409
-9,560
-20% -$1.63M 0.23% 89
2024
Q3
$8.42M Sell
48,969
-1,462
-3% -$242K 0.36% 54
2024
Q2
$7.77M Buy
50,431
+1,828
+4% +$274K 0.29% 68
2024
Q1
$7.47M Buy
48,603
+1,263
+3% +$193K 0.31% 66
2023
Q4
$7.47M Buy
+47,340
New +$6.8M 0.41% 56
2023
Q2
Sell
-46,523
Closed -$7.28M 1186
2023
Q1
$7.28M Sell
46,523
-1,399
-3% -$220K 0.37% 51
2022
Q4
$7.39M Sell
47,922
-500
-1% -$73.8K 0.34% 61
2022
Q3
$6.39M Buy
48,422
+794
+2% +$111K 0.38% 54
2022
Q2
$6.46M Buy
47,628
+1,275
+3% +$176K 0.37% 53
2022
Q1
$6.91M Buy
46,353
+3,965
+9% +$587K 0.25% 65
2021
Q4
$6.87M Buy
+42,388
New +$6.85M 0.25% 75

Other funds holding FBT

Ameritas Advisory Services's FBT Position: Q2 2026 in Review

Ameritas Advisory Services sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 29,143 shares — an estimated $5.85M sold.

Ameritas Advisory Services first reported a position in FBT in Q4 2021 and held it in 16 quarters. The position peaked at $8.42M in Q3 2024. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Ameritas Advisory Services reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
  • Ameritas Advisory Services sold 29,143 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $5.85M.
  • Ameritas Advisory Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2021 and held it in 16 quarters.
  • Ameritas Advisory Services's First Trust NYSE Arca Biotechnology Index Fund position peaked at $8.42M in Q3 2024.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.